Hjem › Akut myelogen leukemi › Georgia › Atlanta
Kliniske studier for Akut myelogen leukemi i Atlanta, GA
31 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Atlanta (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
RekruttererFase 1
- Children'S Healthcare Of Atlanta - Arthur M. Blank Hospital /ID# 275740, Atlanta
Ivosidenib as Post-HSCT Maintenance for AML
RekruttererFase 2
- Emory University Hospital, Atlanta
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
RekruttererFase 1
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
RekruttererFase 2/3
- Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Atlanta VA Medical Center, Decatur · 6 mi unna
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
RekruttererFase 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
- Emory University, Atlanta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruttererFase 1/2
- Emory Winship Cancer Institute, Atlanta
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
- Winship Cancer Institute - Emory University, Atlanta
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
RekruttererFase 3
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RekruttererFase 3
- US-Atlanta GA-EMORY, Atlanta
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
RekruttererFase 3
- US-Atlanta GA-EMORY, Atlanta
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- Children's Healthcare of Atlanta, Atlanta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
RekruttererFase 1
- Children's Healthcare of Atlanta, Atlanta
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- Northside Hospital, Atlanta
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
RekruttererFase 3
- Emory University - Winship Cancer Institute (WCI), Atlanta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
RekruttererFase 1/2
- Emory Winship Cancer Institute, Atlanta
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Winship Cancer Institute / Emory University, Atlanta
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- University of Emory - Winship Cancer Institute, Atlanta
Pilot Imaging Study of Leukemia
RekruttererFase 1
- Emory University, Atlanta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- Emory Healthcare - The Emory Clinic, Atlanta
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Northside Hospital, Atlanta
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
RekruttererFase 1
- Emory University Hospital, Atlanta
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
RekruttererFase 1
- Emory University - WINSHIP Cancer Center, Atlanta
- Emory University, Children's Healthcare of Atlanta, Atlanta
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Blood and Marrow Transplant Group of Georgia, Atlanta
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
RekruttererFrivillige helsepersonell ønskes velkommen
- Emory University, Atlanta
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
- Washington, DC24 studier
Andre studier i Atlanta
- Kreft (alle typer)49 studier
- Ikke-småcellet lungekreft47 studier
- Multipelt myelom42 studier
- Brystkreft41 studier
- Prostatakreft33 studier
- Eggstokkreft29 studier
- Kolorektal kreft29 studier
- Lungekreft29 studier
- Metastatisk kreft28 studier
- Major depresjon25 studier
- Hjertesvikt25 studier
- Plateepitelcancer i hode og hals24 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.